Health News
Rep. Carter: 340b drug discount program lacks ‘appropriate oversight, transparency, and accountability’
U.S. Rep. Earl L. “Buddy” Carter (R-GA-1) said Congress must work to add "transparency, oversight, and sustainability' to a federal drug program that enables eligible hospitals and healthcare organizations to purchase outpatient medications at significantly discounted prices.
J&J proposes ‘trust, but verify’ strategy for federal drug program in which six SE Georgia hospitals participate
91 Georgia hospitals, including seven hospitals in Southeast Georgia, participate in a federal drug program that enables eligible hospitals and healthcare organizations to purchase outpatient medications at significantly discounted prices.
Latest News
